Rho kinase (ROCK) inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rho kinase (ROCK) inhibitor, covering 2017-03-29 to 2022-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 [Phase 2]